Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-24 4:32 pm Purchase | 2024-04-15 | 13G | PRF TECHNOLOGIES LTD SHS 2 PRFX | Mitchell P. Kopin | 1,680 7.900% | 1,680 (New Position) | Filing |
| 2024-04-17 4:03 pm Purchase | 2024-04-08 | 13G | LONGEVERON INC LGVN | Mitchell P. Kopin | 174,054 4.990% | 174,054 (New Position) | Filing History |
| 2024-04-03 5:44 pm Purchase | 2024-03-25 | 13G | BIO-PATH HLDGS INC PAR $0. BPTH | Mitchell P. Kopin | 53,700 7.100% | 45,503 (+555.12%) | Filing History |
| 2024-03-21 4:42 pm Purchase | 2024-03-12 | 13G | ASLAN PHARMACEUTICALS LTD SPON ASLN | Mitchell P. Kopin | 3,125,000 4.400% | 3,125,000 (New Position) | Filing History |
| 2024-03-14 5:10 pm Purchase | 2024-03-04 | 13G | BONE BIOLOGICS CORP COM DE BBLG | Mitchell P. Kopin | 16,601 9.990% | 11,925 (+255.03%) | Filing History |
| 2024-03-06 4:09 pm Purchase | 2024-02-26 | 13G | ACLARION INC ACON | Mitchell P. Kopin | 42 4.990% | 42 (New Position) | Filing History |
| 2024-03-01 4:28 pm Purchase | 2024-02-22 | 13G | VENUS CONCEPT INC VERO | Mitchell P. Kopin | 29,160 4.990% | 29,160 (New Position) | Filing History |
| 2024-02-12 06:16 am Purchase | 2024-02-02 | 13G | NUVVE HOLDING CORP. COM NVVE | Mitchell P. Kopin | 1,027 8.900% | 1,027 (New Position) | Filing History |
| 2024-02-06 11:12 am Purchase | 2023-12-31 | 13G | BAUDAX BIO INC PAR $0.01 BXRXQ | Mitchell P. Kopin | 814,383 1.800% | 787,291 (+2905.99%) | Filing History |
| 2024-02-06 10:30 am Sale | 2023-12-31 | 13G | OCEANPAL INC PAR $0.01 OPXXXX | Mitchell P. Kopin | 105,655 1.400% | -2,636,515 (-96.15%) | Filing History |
| 2024-02-06 10:30 am Purchase | 2023-12-31 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Mitchell P. Kopin | 99,045 9.990% | 8,841 (+9.80%) | Filing History |
| 2024-02-06 10:29 am Purchase | 2023-12-31 | 13G | PALISADE BIO INC PALI | Mitchell P. Kopin | 12,035 1.900% | 3,296 (+37.72%) | Filing History |
| 2024-02-06 10:27 am Sale | 2023-12-31 | 13G | KIORA PHARMACEUTICALS INC KPRX | Mitchell P. Kopin | 13,012 1.500% | -6,185 (-32.22%) | Filing History |
| 2024-02-06 10:24 am Unchanged | 2023-12-31 | 13G | NAYA BIOSCIENCES, INC. NAYA | Mitchell P. Kopin | 15,333 6.900% | 0 (Unchanged) | Filing History |
| 2024-02-06 10:24 am Purchase | 2023-12-31 | 13G | PERFORMANCE SHIPPING INC P PSHG | Mitchell P. Kopin | 472,800 3.900% | 206,134 (+77.30%) | Filing History |
| 2024-02-06 10:23 am Sale | 2023-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Mitchell P. Kopin | 6,191 6.600% | -495 (-7.40%) | Filing History |
| 2024-02-06 10:22 am Sale | 2023-12-31 | 13G | HELIUS MED TECHNOLOGIES INC CO HSDT | Mitchell P. Kopin | 1 0.100% | -39 (-97.50%) | Filing History |
| 2024-02-06 10:19 am Sale | 2023-12-31 | 13G | GUARDION HEALTH SCIENCES INC C GHSI | Mitchell P. Kopin | 50,000 3.800% | -4,950,000 (-99.00%) | Filing History |
| 2024-02-06 10:17 am Sale | 2023-12-31 | 13G | ENVERIC BIOSCIENCES INC NE ENVB | Mitchell P. Kopin | 12,083 6.200% | -5,095 (-29.66%) | Filing History |
| 2024-02-06 10:16 am Purchase | 2023-12-31 | 13G | SYNAPTOGENIX INC SNPX | Mitchell P. Kopin | 41,929 4.990% | 10,461 (+33.24%) | Filing History |